切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 最新上傳

最新上傳
(
  • 熱門
)

最新上傳

(
  • 熱門
)
PD06-1: Prader-Willi Syndrome patients and low urinary tract dysfunction
2020-06-09
PD05-6: Combined immune checkpoint inhibitors in the frontline treatment of metastatic renal cell carcinoma—a real-world experience
2020-06-09
PD05-5: The effect of Metastasectomy on overall survival in metastatic renal cell carcinoma: systemic review and meta-analysis
2020-06-09
PD05-4: Active contour model of machine learning to evlauate the kidney cancer
2020-06-09
PD05-3: Pathological node-positive renal cell carcinoma is associated with worse survival outcome: A recall for TMN staging revision
2020-06-09
PD05-2: Tumor Volume, time to PSA nadir and PSA decline rate influence outcomes in metastatic prostate cancer receiving androgen deprivation therapy
2020-06-09
PD05-1: Factor evaluation of chemotherapy-naïve Enzalutamide on castration- resistant prostate cancer patients—Taiwanese cohort
2020-06-09
PD04-6: Restricted dietary sodium intake in hyperoxaluric rats increases the risk of calcium oxalate nephrolithiasis
2020-06-09
PD04-5: Meta-analysis of postoperative sepsis and systemic inflammatory response syndrome of positive stone bacterial culture for tubeless mini-percutaneous nephrolithotomy
2020-06-09
PD04-4: Ureterorenoscopic lithotripsy and balloon dilation cause acute kidney injury and distal renal tubule damage
2020-06-09
PD04-3: Poor diabetes control impair the function of tamm-horsfall protein on crystal aggregation inhibition
2020-06-09
PD04-2: A comparative study of simultaneous supine percutaneous nephrolithotomy with ureteroscopic lithotripsy and semi-rigid ureteroscopic lithotripsy in the management of large proximal ureteral calculi
2020-06-09
PD04-1: The influence of tumor necrosis factor inhibitor on calcium oxalate crystal formation and adhesion protein expression of hyperoxaluria rat kidney
2020-06-09
PD03-6: Evaluating the risk factors for recurrent uncomplicated urinary tract infections in women
2020-06-09
PD03-5: The efficacy of pentosan polysulfate sodium therapy for preventing urinary tract infections in rats
2020-06-09
PD03-4: Antibacterial photodynamic therapy mediated by methylene blue for Escherichia coli: An alternative treatment choice for drug-resistant urinary tract infection
2020-06-09
PD03-3: Validation of the Age-adjusted Charlson comorbidity index to stratify the mortality risk of Fournier’s gangrene with Taiwan national health insurance research database
2020-06-09
PD03-2: Contemporary, single-institution nomogram predicting progression in non-muscle invasive bladder urothelial carcinoma patients
2020-06-09
PD03-1: Contemporary, single-institution nomogram predicting progression in non-muscle invasive bladder urothelial carcinoma patients
2020-06-09
PD02-6: The performance of MR/US fusion-targeted prostate biopsy in patients with previous negative biopsies–experience in a single institute
2020-06-09
PD02-5: Vesicourethral anastomosis leakage after robotic assisted laparoscopic prostatectomy
2020-06-09
PD02-4: MRI-TRUS fusion-targeted prostate biopsy alone compared with systematic biopsy in detecting significant prostate cancer
2020-06-09
PD02-3: PSA kinetics parameter in prediction of progression of mCRPC
2020-06-09
PD02-2: A multicentre evaluation of the role of the prostate health index (PHI) in regions with differing prevalence of prostate cancer:PHI ≧ 30/35 seems to be the suitable standard to suggest prostate biopsy in Taiwanese with tPSA 4-10 ng/ml
2020-06-09
  • <
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • >
/ 127
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw